Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
Feb 27, 2018 $4.50 $4.50 $4.17 $4.20 1 029 996
Feb 26, 2018 $4.10 $4.33 $3.90 $4.25 1 416 111
Feb 23, 2018 $3.75 $3.91 $3.66 $3.89 808 093
Feb 22, 2018 $3.50 $3.75 $3.48 $3.72 850 851
Feb 21, 2018 $3.66 $3.95 $3.54 $3.56 1 064 841
Feb 20, 2018 $3.14 $3.67 $3.10 $3.57 1 583 280
Feb 16, 2018 $3.15 $3.36 $3.14 $3.18 632 087
Feb 15, 2018 $3.22 $3.22 $3.10 $3.18 399 400
Feb 14, 2018 $3.07 $3.21 $3.07 $3.15 178 300
Feb 13, 2018 $3.03 $3.19 $3.01 $3.10 256 167
Feb 12, 2018 $3.14 $3.18 $3.01 $3.07 181 387
Feb 09, 2018 $3.05 $3.15 $2.97 $3.14 534 591
Feb 08, 2018 $3.04 $3.07 $2.88 $3.01 332 600
Feb 07, 2018 $3.01 $3.11 $2.95 $3.04 259 097
Feb 06, 2018 $2.87 $3.01 $2.81 $3.00 465 935
Feb 05, 2018 $3.06 $3.13 $2.97 $2.98 316 347
Feb 02, 2018 $3.13 $3.18 $2.98 $3.12 293 509
Feb 01, 2018 $3.43 $3.48 $3.14 $3.16 284 826
Jan 31, 2018 $3.62 $3.63 $3.38 $3.39 333 111
Jan 30, 2018 $3.46 $3.63 $3.34 $3.60 275 048
Jan 29, 2018 $3.57 $3.58 $3.48 $3.51 359 732
Jan 26, 2018 $3.57 $3.66 $3.50 $3.57 223 149
Jan 25, 2018 $3.49 $3.61 $3.33 $3.57 389 900
Jan 24, 2018 $4.00 $4.04 $3.44 $3.54 711 600
Jan 23, 2018 $3.99 $4.16 $3.96 $4.01 950 686
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT